134 related articles for article (PubMed ID: 35572890)
21. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
[TBL] [Abstract][Full Text] [Related]
22. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
[TBL] [Abstract][Full Text] [Related]
23. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
24. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
Tuğcu A; Yildirimtürk O; Aytekin S
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
[TBL] [Abstract][Full Text] [Related]
25. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
26. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
[TBL] [Abstract][Full Text] [Related]
27. Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.
Gergei I; Krämer BK; Scharnagl H; Stojakovic T; März W
Peptides; 2019 Jan; 111():112-117. PubMed ID: 29684593
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
[TBL] [Abstract][Full Text] [Related]
29. Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction.
Zhang S; Jin R; Li B
Exp Ther Med; 2021 May; 21(5):446. PubMed ID: 33747182
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
[TBL] [Abstract][Full Text] [Related]
31. Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction.
Luo H; Weerts J; Bekkers A; Achten A; Lievens S; Smeets K; van Empel V; Delhaas T; Prinzen FW
Eur Heart J Digit Health; 2023 Jan; 4(1):4-11. PubMed ID: 36743874
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study on the clinical significance of cardiac computed tomography in heart failure patients with preserved ejection fraction.
Xin JF; Zhang LY; Liu XF; Huang LL; Fang QJ; Lin LJ
Ann Transl Med; 2022 Dec; 10(24):1319. PubMed ID: 36660728
[TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
[No Abstract] [Full Text] [Related]
35. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
36. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients.
Berezin AA; Fushtey IM; Berezin AE
J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050233
[TBL] [Abstract][Full Text] [Related]
37. Echocardiographic parameters differentiating heart failure with preserved ejection fraction from asymptomatic left ventricular diastolic dysfunction.
Ibrahim IM; Hafez H; Al-Shair MHA; El Zayat A
Echocardiography; 2020 Feb; 37(2):247-252. PubMed ID: 31944376
[TBL] [Abstract][Full Text] [Related]
38. Screening for asymptomatic heart failure with preserved ejection fraction in mongolian population at high risk.
Unurjargal T; Khorloo C; Ulziisaikhan G; Sodovsuren N; Khasag A
Kardiologiia; 2020 Mar; 60(4):86-90. PubMed ID: 32394862
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
